Reconstituted HDL as a therapeutic delivery device.

Area of Science:

• Biochemistry
• Nanotechnology
• Cardiovascular Research

Background:

• Pre-beta high-density lipoprotein (HDL) and reconstituted HDL (rHDL) are crucial for understanding reverse cholesterol transport.
• Discoidal rHDL can be easily generated in vitro, enabling diverse applications.

Purpose of the Study:

• To review the applications of bioactive agent-containing rHDL.
• To discuss the incorporation of hydrophobic molecules and lipids into rHDL for targeted delivery.

Main Methods:

• Review of existing literature on rHDL generation and applications.
• Analysis of studies incorporating hydrophobic bioactive molecules into rHDL.
• Examination of lipid and synthetic analog modifications for binding activity.

Main Results:

• rHDL serves as a platform for atherosclerosis regression therapy.
• rHDL acts as a miniature membrane for native-like protein conformation.
• Hydrophobic bioactive molecules and specific lipids/analogs can be incorporated into rHDL for delivery.

Conclusions:

• Bioactive agent-containing rHDL represents a promising nanotechnology for therapeutic delivery.
• Further research is needed to fully realize the potential of these nanoparticles.